Investor Relations
Building Long-term Value
Driving sustainable growth and shareholder returns
Kabra Drugs Limited has consistently delivered strong financial performance while maintaining our commitment to quality healthcare solutions. Our focus on innovation, operational excellence, and strategic expansion has positioned us for sustainable long-term growth.
Annual Reports
Comprehensive financial statements and performance reviews detailing our business operations, achievements, and strategic outlook.
Latest Annual Report
Financial Year 2024
FY 2024 Annual Report Highlights
Our latest annual report provides comprehensive insights into our financial performance, strategic initiatives, corporate governance practices, and future outlook. It includes detailed financial statements, management commentary, and key business developments for the financial year.
Financial Performance
Comprehensive financial statements and analysis
Director's Report
Strategic overview and corporate governance
Report Details
- Financial Year:FY 2024
- Document Type:Annual Report
- Format:PDF
- Download
Recent Annual Reports
Annual Report 2023
Financial Year 2023
MGT 7 2022
Financial Year 2022
Historical Annual Reports Archive
Understanding Annual Reports
Annual reports provide a comprehensive overview of our company's activities, financial performance, and strategic direction throughout the fiscal year. These documents include audited financial statements, management discussions, and analyses of our business operations. They serve as a vital resource for shareholders, investors, and other stakeholders to evaluate our financial health and corporate governance practices.
Need More Information?
Our Investor Relations team is dedicated to providing you with the information you need. Feel free to reach out with any questions.
Company Policies
Our corporate policies reflect our commitment to ethical business practices, transparency, and good governance.
Corporate Policies
Framework for governance and ethical business conduct
At Kabra Drugs Limited, we are committed to maintaining the highest standards of corporate governance and ethical behavior. Our policies are designed to ensure transparency, accountability, and compliance with regulatory requirements while safeguarding the interests of all stakeholders.
WHISTLE BLOWER POLICY CUM VIGIL MECHANISM
Policy for reporting unethical behavior and protection of whistleblowers
POLICY ON RELATED PARTY TRANSACTION
Guidelines for handling transactions with related parties
COMPOSITION OF BOARD OF DIRECTOR'S
Details of the board composition and committee structure
CODE OF CONDUCT
Ethical guidelines and standards for the company
TERMS AND CONDITIONS OF APPOINTMENT OF INDEPENDENT DIRECTORS
Guidelines for the appointment and role of independent directors
Governance Framework
These policies form the cornerstone of our corporate governance framework. They are regularly reviewed and updated to ensure compliance with changing regulatory requirements and best practices in corporate governance. Our Board of Directors oversees the implementation of these policies to maintain the highest standards of ethics and transparency.
Compliance
Access our quarterly regulatory filings and compliance documentation that demonstrate our commitment to transparency and corporate governance.
Regulatory Compliance
Quarterly and yearly regulatory filings
At Kabra Drugs Limited, we maintain the highest standards of corporate governance through strict adherence to regulatory requirements and transparent disclosures. Below you'll find our quarterly compliance reports filed with regulatory authorities.
Timely Disclosures
All regulatory filings submitted within mandated timeframes
Complete Transparency
Full access to all compliance documentation
2024 Quarterly Reports
Quarterly Reports December 31, 2024
Q4 2024
Quarterly Reports September 30, 2024
Q3 2024
Quarterly Reports June 30, 2024
Q2 2024
Quarterly Reports March 31, 2024
Q1 2024
Historical Compliance Reports (2023-2020)
Understanding Compliance Documents
These regulatory filings demonstrate our adherence to SEBI regulations and other statutory requirements. Our compliance documentation includes trading window notifications, reconciliation reports, share capital audits, and other regulatory filings that ensure transparency in our corporate governance practices.
Notices & Announcements
Stay updated with the latest regulatory filings, disclosures, and company announcements.
Stay Updated
Subscribe to receive the latest announcements and updates directly to your email inbox.
You can unsubscribe at any time
Quarterly Financial Reports
Our quarterly financial statements provide detailed insights into our operational performance, revenue streams, profit margins, and growth trajectory. These reports are essential for stakeholders to evaluate our financial health and make informed investment decisions.
Latest Quarterly Reports
These financial statements contain detailed information about our operations, cash flows, and balance sheet positions. We publish these reports quarterly as part of our commitment to transparency and regulatory compliance.
Unaudited Financial Result For Quarter Ending 31st December, 2024
December 31, 2024
Download ReportUnaudited Financial Result For Quarter Ending 30th September, 2024
September 30, 2024
Download ReportUnaudited Financial Result For Quarter Ending 30th June, 2024
June 30, 2024
Download ReportAudited Financial Result For Quarter Ending 31st March, 2024
March 31, 2024
Download ReportUnderstanding Our Financial Reports
Learn how to interpret key metrics and data points in our quarterly financial statements.
Audited vs. Unaudited Reports
Audited reports (typically annual) have been verified by independent auditors, while unaudited reports (typically quarterly) are prepared by our finance team without external verification.
Quarterly Cycle
Q1 (Apr-Jun), Q2 (Jul-Sep), Q3 (Oct-Dec), and Q4 (Jan-Mar) reports provide a regular cadence of financial information throughout our fiscal year.
Key Financial Statements
Each report contains a balance sheet (assets & liabilities), income statement (revenue & expenses), and cash flow statement (cash movements).
Management Discussion
Each report includes analysis from management on performance drivers, challenges, and future outlook for the company.
Financial Reports Archive
Access our complete historical financial statements by year and quarter. All reports are available for download in PDF format and comply with regulatory reporting requirements.
Annual Reports
Access our comprehensive annual reports with detailed financial analysis, business reviews, and strategic outlooks.
Investor Presentations
Review our latest investor presentations with key metrics, growth projections, and strategic initiatives.
Need historical disclosures?
Access our complete archive of regulatory filings and corporate announcements.